Deals and Financings Novartis (NVS) signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA…
Receive free Disease control and prevention updatesWe’ll send you a myFT Daily Digest email rounding up the latest Disease control…
By Alexander Marrow (Reuters) - The rouble weakened against the dollar on Friday after the Bank of Russia hiked rates…
Amidst the dynamic and ever-changing landscape of the cryptocurrency market, Bitcoin's recent performance has been under scrutiny. Currently trading at 29,890,…
Foolishness sleeps soundly, while knowledge turns with each thinking hour, longing for the dawn of answers.”― Anthony Liccione Today, we…
Receive free Global Economy updatesWe’ll send you a myFT Daily Digest email rounding up the latest Global Economy news every…
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed…
Sign in to your account
